Ricardo Zayas - Aug 1, 2023 Form 4 Insider Report for Catalent, Inc. (CTLT)

Role: SVP, Operations, Biologics NA
Signature: /s/ Amy Fallone, attorney-in-fact
Stock symbol: CTLT
Transactions as of: Aug 1, 2023
Transactions value $: $0
Form type: 4
Date filed: 8/3/2023, 05:17 PM
Previous filing: Feb 6, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CTLT	Common Stock	Award	$0	+4.44K	+248.04%	$0.00	6.22K	Aug 1, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTLT	Options to purchase Common Stock	Award	$0	+9.88K		$0.00	9.88K	Aug 1, 2023	Common Stock	9.88K	$46.51	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur in three equal annual installments beginning on August 1, 2024.
F2	Represents restricted stock units.
F3	Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan.
F4	The options vest and become exercisable in four equal annual installments beginning on August 1, 2024.